The potential of any substance to cause cancer.
Glossary
Carcinogenic
02.27.12
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Breaking News | Collaborations & Alliances | Drug Development | Industry News | Preclinical Outsourcing | R&D
Nektar and Takeda in Research Collaboration
Will explore combination cancer therapies
-
Bio News | Breaking News | Clinical Trials | Collaborations & Alliances | Industry News
Merck Teams With Aduro Biotech on Cancer Drug Trial
Will evaluate the combination of Aduro’s CRS-207 with Merck’s Keytruda
-
Collaborations & Alliances | Drug Development
BMS, Calithera Biosciences Expand Clinical Collaboration
Will evaluate Opdivo in combination with CB-839 in NSCLC and Melanoma
-
Breaking News | cGMP Manufacture | Formulation Development | Industry News | Solid Dosage/Creams/Ointments
Catalent Manufactures Lexicon’s Xermelo Following Approval
To provide commercial supply of first-in-class oral therapy from its Kansas City facility
